Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development
JMIR Public Health and Surveillance · 2025
DOI: 10.2196/66309 ↗At a glance
Journal article in JMIR Public Health and Surveillance, 2025. Written by Julien Smith-Roberge and 5 co-authors. Institution: School of Pharmacy, University of Waterloo, 10A Victoria St. S., Kitchener, ON, N2G 1C5, Canada, 1 519-888-4567 ext 21323. Major MEDLINE topics: Hepatitis B, Chronic. 24 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Chronic hepatitis B (CHB) remains a significant health burden for at least a hundred thousand Canadians. The government of Canada has endorsed the global strategy to eliminate hepatitis as a public health threat by 2030, but effectively targeting public health interventions is complicated by the silent nature of the disease, which can remain asymptomatic for decades.
Objective
This study develops a framework to estimate the prevalence of CHB and the proportion of the infected population that remains undiagnosed. We apply the proposed method to national data from Canada, from 2007 to 2021.
Methods
We infer the prevalence and undiagnosed proportion of CHB by fitting a mathematical state-transition model, based on the natural history of CHB, to observed CHB-related events. Data for the calibration were obtained from the Public Health Agency of Canada and Statistics Canada.
Results
We estimate the national prevalence of CHB in Canada in 2021 to be 0.483% (95% CI 0.443%-0.535%). The corresponding percentage of undiagnosed cases was estimated to be 54.3% (95% CI 50.9%-58.9%).
Conclusions
The estimates of CHB prevalence obtained via our method are in line with previous estimates obtained from national seroprevalence studies. More specialized estimates, stratified by province or age cohort, may be achievable with detailed health administrative data.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Pharmacy, University of Waterloo, 10A Victoria St. S., Kitchener, ON, N2G 1C5, Canada, 1 519-888-4567 ext 21323.
- Department of Mathematics and Statistics, University of Guelph, Guelph, ON, Canada.
- Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada.
ORCID profiles: Julien Smith-Roberge, Farinaz Forouzannia, Abdullah Hamadeh, Zeny Feng, Nashira Popovic, William W L Wong
Cite
APA
Smith-Roberge, J., Forouzannia, F., Hamadeh, A., Feng, Z., Popovic, N., & Wong, W. W. L. (2025). Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development. JMIR Public Health and Surveillance. https://doi.org/10.2196/66309
Vancouver
Smith-Roberge J, Forouzannia F, Hamadeh A, Feng Z, Popovic N, Wong WWL. Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development. JMIR Public Health and Surveillance. 2025. doi:10.2196/66309
BibTeX
@article{SmithRoberge2025,
author = {Smith-Roberge, Julien and Forouzannia, Farinaz and Hamadeh, Abdullah and Feng, Zeny and Popovic, Nashira and Wong, William W L},
title = {Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development},
journal = {JMIR Public Health and Surveillance},
year = {2025},
doi = {10.2196/66309}
}
EUVIMED